Masterclass: Regulation of DTx in the US - Experience from a Real Company

Having regulatory clearance is absolutely essential for many DTx companies to successfully bring their solution to market. Most times, knowing what is on the books is not enough to understand how you should navigate the regulatory landscape in practice. In this masterclass, we will hear about the experience from a real company; Michelle Rubin-Onur, Director of Regulatory at Blue Note Therapeutics, will walk us through the following: